| Interpreting tacrolimus concentrations during pregnancy and postpartum MF Hebert, S Zheng, K Hays, DD Shen, CL Davis, JG Umans, ... Transplantation 95 (7), 908-915, 2013 | 139 | 2013 |
| Pharmacokinetics of tacrolimus during pregnancy S Zheng, TR Easterling, JG Umans, M Miodovnik, JC Calamia, ... Therapeutic drug monitoring 34 (6), 660-670, 2012 | 113 | 2012 |
| Simultaneous measurement of plasma vitamin D 3 metabolites, including 4β, 25-dihydroxyvitamin D 3, using liquid chromatography–tandem mass spectrometry Z Wang, T Senn, T Kalhorn, XE Zheng, S Zheng, CL Davis, MF Hebert, ... Analytical biochemistry 418 (1), 126-133, 2011 | 105 | 2011 |
| Tacrolimus Placental Transfer at Delivery and Neonatal Exposure through Breast Milk MFH Songmao Zheng, Thomas R. Easterling, Karen Hays British Journal of Clinical Pharmacology, 2013 | 81 | 2013 |
| Measurement and compartmental modeling of the effect of CYP3A5 gene variation on systemic and intrarenal tacrolimus disposition S Zheng, Y Tasnif, MF Hebert, CL Davis, Y Shitara, JC Calamia, YS Lin, ... Clinical Pharmacology & Therapeutics 92 (6), 737-745, 2012 | 64 | 2012 |
| Model‐Based Cellular Kinetic Analysis of Chimeric Antigen Receptor‐T Cells in Humans C Liu, VS Ayyar, X Zheng, W Chen, S Zheng, H Mody, W Wang, D Heald, ... Clinical Pharmacology & Therapeutics 109 (3), 716-727, 2021 | 55 | 2021 |
| A Long-Acting PYY3–36 Analog Mediates Robust Anorectic Efficacy with Minimal Emesis in Nonhuman Primates SM Rangwala, K D’Aquino, YM Zhang, L Bader, W Edwards, S Zheng, ... Cell metabolism 29 (4), 837-843. e5, 2019 | 50 | 2019 |
| Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects S Zheng, P Matzneller, M Zeitlinger, S Schmidt Antimicrobial agents and chemotherapy 58 (11), 6675-6684, 2014 | 45 | 2014 |
| CYP3A5 gene variation influences cyclosporine A metabolite formation and renal cyclosporine disposition S Zheng, Y Tasnif, MF Hebert, CL Davis, Y Shitara, JC Calamia, YS Lin, ... Transplantation 95 (6), 821-827, 2013 | 45 | 2013 |
| Cross-arm binding efficiency of an EGFR x c-Met bispecific antibody S Zheng, S Moores, S Jarantow, J Pardinas, M Chiu, H Zhou, W Wang MAbs 8 (3), 551-561, 2016 | 42 | 2016 |
| Evaluation of changes in oral drug absorption in preterm and term neonates for Biopharmaceutics Classification System (BCS) class I and II compounds AA Somani, K Thelen, S Zheng, MN Trame, K Coboeken, M Meyer, ... British journal of clinical pharmacology 81 (1), 137-147, 2016 | 39 | 2016 |
| Utility of free and total target measurements as target engagement and efficacy biomarkers in biotherapeutic development—opportunities and challenges S Zheng, T McIntosh, W Wang The Journal of Clinical Pharmacology 55 (S3), S75-S84, 2015 | 37 | 2015 |
| Rapid purification of human bispecific antibodies via selective modulation of protein A binding A Zwolak, CN Leettola, SH Tam, DR Goulet, MG Derebe, JR Pardinas, ... Scientific Reports 7 (1), 15521, 2017 | 27 | 2017 |
| Model-Based Assessment of Dosing Strategies in Children for Monoclonal Antibodies Exhibiting Target-Mediated Drug Disposition LJLSS S Zheng, P Gaitonde, M A Andrew, M A Gibbs CPT Pharmacometrics Syst. Pharmacol., 2014 | 23 | 2014 |
| Minimal Physiologically Based Pharmacokinetic-Pharmacodynamic (mPBPK-PD) Model of N-Acetylgalactosamine–Conjugated Small Interfering RNA Disposition and Gene Silencing in … VS Ayyar, D Song, S Zheng, T Carpenter, DL Heald Journal of Pharmacology and Experimental Therapeutics 379 (2), 134-146, 2021 | 22 | 2021 |
| Systems approaches in risk assessment LJ Lesko, S Zheng, S Schmidt Clinical Pharmacology & Therapeutics 93 (5), 413-424, 2013 | 22 | 2013 |
| ADME and translational pharmacokinetics/pharmacodynamics of therapeutic proteins: applications in drug discovery and development H Zhou, FP Theil John Wiley & Sons, 2015 | 18 | 2015 |
| Amino Acids Are Sensitive Glucagon Receptor Specific Biomarkers for Glucagon‐Like Peptide 1 Receptor/Glucagon Receptor Dual Agonists W Li, T Kirchner, G Ho, F Bonilla, K D'Aquino, J Littrell, R Zhang, W Jian, ... Diabetes, Obesity and Metabolism, 2020 | 12 | 2020 |
| Multivalent human antibody-centyrin fusion protein to prevent and treat Staphylococcus aureus infections PT Buckley, R Chan, J Fernandez, J Luo, KA Lacey, AL DuMont, ... Cell Host & Microbe 31 (5), 751-765. e11, 2023 | 11 | 2023 |
| Seattle Genetics rare cancer drug sails through accelerated approval SB Zheng Nature biotechnology 29 (10), 851, 2011 | 9 | 2011 |
Stephan SchmidtAssociate Professor of Pharmacy, University of FloridaVerified email at cop.ufl.edu
